| Name | TAPI 0 | 
|---|---|
| Synonyms | 
                                
                                N-[(2R)-2-[2-(Hydroxyamino)-2-oxoethyl]-4-methyl-1-oxopentyl]-3-(2-naphthalenyl)-L-alanyl-L-alaninamide
                                
                                
                                 TAPI-0 TNF-α Protease Inhibitor-0 N-(R)-(2-(Hydroxyaminocarbonyl)Methyl)-4-Methylpentanoyl-L-Naphthylalanyl-L-Alanine amide MFCD02684279 TNF-α Processing Inhibitor-0  | 
                        
| Description | TAPI-0 is a TACE (TNF-α converting enzyme; ADAM17) inhibitor with an IC50 of 100 nM. TAPI-0 is a MMP inhibitor and also attenuates TNF-α processing[1][2]. | 
|---|---|
| Related Catalog | |
| Target | 
                                
                                 IC50: 100 nM (TACE)[2]  | 
                        
| In Vitro | TAPI-0 inhibits peptide deformylase (PDF) with an IC50 of 18 nM. TAPI-0 suppresses chlamydial growth by targeting the bacterial PDF[1]. | 
| References | 
| Density | 1.2±0.1 g/cm3 | 
|---|---|
| Molecular Formula | C24H32N4O5 | 
| Molecular Weight | 456.53 | 
| Exact Mass | 456.237274 | 
| LogP | 1.31 | 
| Index of Refraction | 1.587 | 
| Water Solubility | Soluble to 10 (mg/mL) in DMSO | 
| Symbol | 
                                
                                 
                                
                                GHS06  | 
                        
|---|---|
| Signal Word | Danger | 
| Hazard Statements | H301 | 
| Precautionary Statements | P301 + P310 + P330 | 
| RIDADR | UN 2811 6.1 / PGIII |